- Trials with a EudraCT protocol (2)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2 result(s) found for: Computerized adaptive testing.
Displaying page 1 of 1.
EudraCT Number: 2007-005088-82 | Sponsor Protocol Number: CAFQ056A2204 | Start Date*: 2008-05-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multi-centre, randomized, double-blind, placebo-controlled, two-period, crossover proof-of-concept study in patients with Fragile X Syndrome to assess the efficacy, safety and tolerability of mul... | |||||||||||||
Medical condition: Fragile X Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000293-28 | Sponsor Protocol Number: AVB500-OC-004 | Start Date*: 2021-09-07 | |||||||||||
Sponsor Name:Aravive, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Adaptive, Placebo/Paclitaxel-Controlled Study of AVB S6 500 in Combination with Paclitaxel in Patients with Platinum-Resistant Recurrent Ovarian Cancer | |||||||||||||
Medical condition: Platinum-Resistant Recurrent Ovarian Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) PL (Prematurely Ended) CZ (Completed) IT (Prematurely Ended) DE (Completed) BE (Prematurely Ended) GR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
